Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors (Q34111684)

31 July 2017

title

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors (English)

1 reference

31 July 2017

0 references

1 reference

Serradeil-Le Gal C

1

1 reference

31 July 2017

Wagnon J

2

1 reference

31 July 2017

Garcia C

3

1 reference

31 July 2017

Lacour C

4

1 reference

31 July 2017

Guiraudou P

5

1 reference

31 July 2017

Christophe B

6

1 reference

31 July 2017

Villanova G

7

1 reference

31 July 2017

Nisato D

8

1 reference

31 July 2017

Maffrand JP

9

1 reference

31 July 2017

Le Fur G

10

1 reference

31 July 2017

publication date

1 July 1993

1 reference

Journal of Clinical Investigation

31 July 2017

language of work or name

English

0 references

published in

1 reference

31 July 2017

volume

92

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

224-231

1 reference

Some quantitative uses of drug antagonists

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Specific vasopressin binding to rat adrenal glomerulosa cells. Relationship to inositol lipid breakdown

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Nature and properties of human platelet vasopressin receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Characterization of human platelet vasopressin receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Discovery, development, and some uses of vasopressin and oxytocin antagonists

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Hill coefficients and the logistic equation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Subclasses of angiotensin II binding sites and their functional significance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Pharmacology and clinical perspectives of vasopressin antagonists

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Molecular cloning of the receptor for human antidiuretic hormone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Structure and expression of a human oxytocin receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Dose-response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Cardiovascular effects of vasopressin: some recent aspects.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

Benzophenanthridine alkaloids isolated from Eschscholtzia californica cell suspension cultures interact with vasopressin (V1) receptors

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293574

28 October 2018

Vasopressin antagonists

1 reference

12 December 2020

THE AGGREGATION OF BLOOD PLATELETS

1 reference

12 December 2020

Oxytocin and vasopressin: distinct receptors in myometrium

1 reference

12 December 2020

Labelling of vasopressin and oxytocin receptors from the human uterus

1 reference

12 December 2020

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

12 December 2020

Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues

1 reference

12 December 2020

Effects of OPC-21268, an orally effective vasopressin V1 receptor antagonist in humans

1 reference

12 December 2020

Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation

1 reference

12 December 2020

Affinities of reactive vasopressin analogues for bovine antidiuretic receptor

1 reference

12 December 2020

Vasopressin-, angiotensin II-, and alpha 1-adrenergic-induced inhibition of Ca2+ transport by rat liver plasma membrane vesicles

1 reference

12 December 2020

Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI116554

1 reference

31 July 2017

1 reference

31 July 2017

1 reference